ValiRx Plc (LON:VAL) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.17 and traded as low as $0.15. ValiRx shares last traded at $0.17, with a volume of 4,570,512 shares trading hands.
The stock has a fifty day moving average of GBX 0.17 and a 200-day moving average of GBX 0.40. The company has a quick ratio of 0.77, a current ratio of 0.84 and a debt-to-equity ratio of 10.35. The stock has a market capitalization of $1.90 million and a price-to-earnings ratio of -0.21.
About ValiRx (LON:VAL)
ValiRx plc, a biotechnology oncology focused company, engages in developing novel treatments for cancer and associated biomarkers in the United Kingdom. Its proprietary GeneICE technology enables the selective silencing of specific genes by targeted histone deacetylation leading to chromatin condensation.
Read More: What Are Treasury Bonds?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.